Company intelligence / Profile preview

DirectDerm

Palo Alto, California, United States

Ownership: Private
Development stage: Other

Overview

DirectDerm provides rapid, remote diagnosis and treatment planning for all major skin, hair, and nail conditions through board-certified dermatologists, typically delivering reports within 24–48 hours[1][4]. Clinical effectiveness has been demonstrated in underserved and rural patient populations in California[2][3].

Therapeutic areas: CardiovascularEndocrinologyGastroenterologyInfectious DiseasesDermatologyOncology
Modalities: Non-pharmacological therapyDevice
Industry: Non-Academic Healthcare

Partnerships

California Health Care Foundation (as investor/partner in expanding access)[2]health plans and independent physician associations (IPAs)[2]

Beyond the preview

Go deeper on DirectDerm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DirectDerm.

Explore the full profile